Genomic and Molecular Services


MOgene offers cutting edge technology for next-generation sequencing across multiple Illumina instruments, allowing us to match the scope of your projects and return results quickly.

Illumina Platforms
  • Illumina MiSEQ
  • Illumina NextSEQ
  • Targeted resequencing
  • Amplicon sequencing – extremely high depth supports finding rare variants
  • Hybrid capture – Targeted re-sequencing for analysis of specific subset of the genome
  • 16S Metagenomics – The 16s rRNA V4 region sequencing for survey of bacterial diversity
  • Small genome sequencing
  • de novo sequencing – ideal for sequencing small bacterial genomes (< 20Mb)
  • Re-sequencing
  • Clone checking – analysis of plasmid DNA constructs
  • Custom amplicon – TruSeq Custom Amplicon allows sequencing of hundreds of genomic regions covering up to 96 kb of cumulative sequence. This highly targeted approach enables a wide range of applications for discovering, validating, and screening genetic variants in a rapid and efficient manner.
  • RNA sequencing
  • RNA-Seq (microbial)
  • Small RNA sequencing – Enables discovery and profiling of microRNAs and other non-coding RNA.
  • Library QC – For testing library construction.
  • Chip-seq – Chromatin Immunoprecipitation (ChIP)


Quality and safety

The Quality Commitment From MOgene

Regulatory Services

MOgene has an established reputation of complying with relevant national and international quality compliance regulations.

  • Audit ready for clients with routine internal quality audits
  • GLP compliance per FDA 21 CFR Part 58 and Part 11
  • Active CAPA program for process improvement
  • CLIA Certification
  • USDA Certification
Quality Management System

MOgene has a robust Quality Management System (QMS) detailed in a manual that ensures compliance for quality monitoring and improvement.

  • Transparent and routine communications on project timelines and deliverables
  • Complete documentation of standard operating procedures (SOPs) and 100% QC of data
  • Rigorous sample management process

Our Biosafety practices enable us to provide services for early R&D and market release studies for pathogens that require    BSL-2+ facilities.

  • Higher levels of lab safety for antimicrobial, human and animal health vaccine development
  • Dedicated BSL-2+ Lab and pre-amplification room for your clinical studies
  • Trained personnel to handle BSL-2+ level agents
Security and Data Protection

MOgene considers safety and confidentiality a top priority for our client’s data.

  • 24/7/365 temperature and humidity monitoring 
  • Individually coded key access to labs
  • Secured access to data records
  • Daily back-up of data



Supporting Genomic Studies Since 2004
Industry Leading Experienced Team
More Than 150 Citations in Peer-reviewed Journals
Quote Request

Contact Us